|
|
The Effects of Bone Morphogenetic Protein 9(BMP9) on the Proliferation and Migration of Human Bladder Cancer BIU-87 Cells |
Li-yao GOU,Meng-yao LIU,Jing XIA,Qun WAN,Chi-lei SUN,Min TANG,Yan ZHANG() |
Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education,Chongqing Medical University, Chongqing 400016, China |
|
|
Abstract Objective:To investigate the effects of bone morphogenetic protein 9 (BMP9) on the proliferation and migration of human bladder cancer BIU-87 cells.Methods:BIU-87 cells were infected with BMP9 recombinant adenovirus(AdBMP9); The mRNA levels of BMP9 were detected by Q-PCR; The BMP9 protein and its downstream associated signaling pathway protein levels were detected by Western blot; The MTT and colony formation assay were used to test the proliferation of BIU-87 cells; The wound healing and Transwell TM chamber assay were taken to evaluate the migration of BIU-87 cells. Results:The expression of BMP9 in BIU-87 cells was highly increased after AdBMP9 infection; Forced expression of BMP9 promotes both the proliferation and migration of BIU-87 cells; Western blot results showed that BMP9 overexpression also increased AKT phosphorylation.Conclusion:High levels of BMP9 may promote the proliferation and migration of bladder cancer BIU-87 cells by activating the AKT signaling pathway.
|
Received: 31 August 2017
Published: 05 June 2018
|
|
Corresponding Authors:
Yan ZHANG
E-mail: zy2753@hotmail.com
|
|
|
[1] |
Siegel R L, Miller K D, Jemal A . Cancer statistics, 2016. Ca A Cancer Journal for Clinicians, 2016,66(1):7.
doi: 10.3322/caac.21332
|
|
|
[2] |
韩苏军, 张思维, 陈万青 , 等. 中国膀胱癌发病现状及流行趋势分析. 癌症进展, 2013,11(1):89-95.
|
|
|
[2] |
Han S J, Zhang S W, Chen W Q , et al. Analysis of the status and trends of bladder cancer incidence in China. Oncology Progress, 2013,11(1):89-95.
|
|
|
[3] |
韩苏军, 张思维, 陈万青 , 等. 中国膀胱癌死亡现状及流行趋势分析. 现代泌尿外科杂志, 2013,18(3):228-232.
|
|
|
[3] |
Han S J, Zhang S W, Chen W Q , et al. Analysis of the status quo and trends: mortality in patients with bladder cancer in China, Journal of Modern Urology, 2013,18(3):228-232.
|
|
|
[4] |
Alarmo E L, Kallioniemi A . Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis. Endocrine-related Cancer, 2010,17(2):R123.
|
|
|
[5] |
Wang K, Feng H, Ren W , et al. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231. Journal of Cancer Research & Clinical Oncology, 2011,137(11):1687-1696.
doi: 10.1007/s00432-011-1047-4
pmid: 21892652
|
|
|
[6] |
Herrera B , García-álvaro M, Cruz S, et al. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells. PLoS One, 2013,8(7):e69535.
doi: 10.1371/journal.pone.0069535
pmid: 3720667
|
|
|
[7] |
Kuzaka B, Janiak M, Włodarski K H , et al. Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence. Archives of Medical Science, 2015,11(2):378-384.
doi: 10.5114/aoms.2014.46796
pmid: 25995755
|
|
|
[8] |
Soloway M S . Editorial comment on: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. European Urology, 2008,54(2):313.
doi: 10.1016/j.eururo.2008.04.052
pmid: 18468783
|
|
|
[9] |
van Rhijn B W, Burger M Y . Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. European Urology, 2009,56(3):430.
doi: 10.1016/j.eururo.2009.06.028
pmid: 19576682
|
|
|
[10] |
Yeung C, Dinh T, Lee J . The health economics of bladder cancer: an updated review of the published literature. Pharmacoeconomics, 2014,32(11):1093-1104.
doi: 10.1007/s40273-014-0194-2
pmid: 25056838
|
|
|
[11] |
Siegel R, Ma J, Zou Z , et al. Cancer statistics, 2014. Ca A Cancer Journal for Clinicians, 2014,64(1):9.
doi: 10.3322/caac.21208
|
|
|
[12] |
Xue M, Xu L I, Wenjing W U , et al. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis. Oncology Reports, 2014,31(5):1993-2000.
doi: 10.3892/or.2014.3092
pmid: 4020618
|
|
|
[13] |
Jacobs B L, Lee C T, Montie J E . Bladder cancer in 2010: how far have we come. Ca A Cancer Journal for Clinicians, 2010,60(4):244-272.
doi: 10.3322/caac.20077
pmid: 20566675
|
|
|
[14] |
葛仙伟, 黄后宝 . 膀胱癌相关分子生物学研究现状. 承德医学院学报, 2017,34(4):329-332.
|
|
|
[14] |
Ge X W, Huang H B . Current status of molecular biology in bladder cancer. Journal of Chengde Medical College, 2017,34(4):329-332.
|
|
|
[15] |
Wu W, Zhang S, Li X , et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One, 2013,8(9):e73920-e73920.
doi: 10.1371/journal.pone.0073920
pmid: 3771932
|
|
|
[16] |
Chen W, Luo K, Ke Z , et al. TBK1 promote bladder cancer cell proliferation and migration via Akt Signaling. Journal of Cancer, 2017,8(10):1892-1899.
doi: 10.7150/jca.17638
pmid: 5556653
|
|
|
[17] |
Chen Z . B7-H3 promotes the migration and invasion of human bladder cancer cells via the PI3K/Akt/STAT3 Signaling pathway. Journal of Cancer, 2017,8(5):816-824.
doi: 10.7150/jca.17759
pmid: 5381170
|
|
|
[18] |
马明, 金国江, 付立业 . 上调microRNA-100对结肠癌HT-29细胞增殖和侵袭的影响. 现代肿瘤医学, 2016,24(7):1031-1033.
doi: 10.3969/j.issn.1672-4992.2016.07.003
|
|
|
[18] |
Ma M, Jin G J, Fu L Y . The effect of up -regulating microRNA -100 in colon cancer HT -29 cells on prolifera-tion and apoptosis. Journal of Modern Oncology, 2016,24(7):1031-1033.
doi: 10.3969/j.issn.1672-4992.2016.07.003
|
|
|
[19] |
Xu C, Zeng Q, Xu W , et al. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Molecular Cancer Therapeutics, 2013,12(2):207.
doi: 10.1158/1535-7163.MCT-12-0273
|
|
|
[20] |
Wang J, Zhang X, Wang L , et al. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer. Journal of Surgical Oncology, 2015,111(8):992.
doi: 10.1002/jso.23937
pmid: 25975233
|
|
|
[21] |
Xing J Z, Hua Y, Cheng W Z , et al. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. Journal of Hematology & Oncology, 2010,3(1):46.
doi: 10.1186/1756-8722-3-46
pmid: 21106054
|
|
|
[22] |
Tao C, Wu C, Hu H . AB266. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Biochemical & Biophysical Research Communications, 2015,468(4):666-670.
doi: 10.21037/tau.2016.s266
pmid: 4842632
|
|
|
[23] |
Zhu H, Li X, Song Y , et al. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun, 2015,467(2):223-228.
doi: 10.1016/j.bbrc.2015.10.002
pmid: 26449463
|
|
|
[24] |
Wang Y, Chen W, Yang C , et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis, of bladder cancer. International Journal of Oncology, 2012,41(1):276.
doi: 10.3892/ijo.2012.1443
pmid: 22576688
|
|
|
[25] |
Liang Z, Wang X, Xu X , et al. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway. Molecular Cancer, 2017,16(1):96.
doi: 10.1186/s12943-017-0664-1
pmid: 28549468
|
|
|
[26] |
Li Y, Shan Z, Liu C , et al. MicroRNA-294 promotes cellular proliferation and motility through the PI3K/AKT and JAK/STAT pathways by upregulation of NRAS in bladder cancer. Biochemistry Biokhimiia, 2017,82(4):474.
doi: 10.1134/S0006297917040095
pmid: 28371605
|
|
|
[27] |
Wu W, Zhang S, Li X , et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One, 2013,8(9):e73920-e73920.
doi: 10.1371/journal.pone.0073920
pmid: 3771932
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|